AI technology has become the ‘shiny new thing’ in the business world, the new tech that transforms industries with ...
Morgan Stanley's strong Q3 performance saw a 17% non-interest revenue increase and a 37% rise in net income. Read more on the ...
Morgan Stanley’s stock (NYSE: MS) gained over 30% year-to-date. This compares to rival Goldman Sachs stock, which has seen ...
Morgan Stanley said Nvidia stock is its top pick heading into 2025, and success of Blackwell should dispel investors' ...
Michael Gapen, chief U.S. economist at Morgan Stanley, and CNBC's Steve Liesman join 'The Exchange' to discuss the latest PCE ...
Barbara Doran, BD8 Capital Partners CEO and Seth Carpenter, Morgan Stanley Global Chief Economist, join 'Closing Bell: ...
Reiterated as a "Top Pick" with an Overweight rating by Morgan Stanley ( NYSE:MS) on Friday, Nvidia ( NASDAQ:NVDA) was cited ...
With CEO Jensen Huang coming to give a keynote presentation, Nvidia's attendance at the Consumer Electronics Show in January ...
Investment bank Morgan Stanley on Friday issued a bullish report on artificial intelligence chipmakers, calling Nvidia stock ...
Morgan Stanley has teamed up with cross-border money transmitter Wise to settle foreign-exchange payments for the investment ...
Morgan Stanley has upgraded PTC Therapeutics (PTCT), while downgrading Immuneering (IMRX) and Amicus Therapeutics (FOLD).
Morgan Stanley (MS) stock saw a decline, ending the day at $120.5 which represents a decrease of $-0.54 or -0.45% from the prior close of $121.04. The stock opened at $124.78 and touched a low of $120 ...